Shopping Cart 0
Cart Subtotal
AED 0

Pharmacy Retail Market in India 2013

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 3487

Details

The new report, "Pharmacy Retail Market in India", elaborates the changing role of pharmacy outlets and the gradual progression it is seeing towards building an organized format. The market is sustainable and is projected towards significant growth due to the already existing varied disease profile as well as the emerging new diseases and the growing population size being affected by such diseases.

The pharmacy sector forms the second largest share in the Indian healthcare sector. The sector sources its products through institutional and non institutional sales. The institutional sales is the sale of pharmaceuticals to hospitals, nursing homes and other such health institutions that purchase bulk drugs at discounted prices that results in partial decline in profit margin of manufacturers. Whereas, non institutional sales takes place through retail stores that happen to be the only form of sales channel that reaches directly to consumers and is a major source of revenue earning for the sector.

The pharmacy sector in India is highly regulated yet the sector suffers from circulation of sub standard and counterfeit drugs which hampers the retail segment of the business. Measures are being taken by the pharmacy regulatory bodies of the country to control the menace as it hampers the revenue earning drastically. The government is also taking major initiatives to provide medicines at subsidized rates as well as engage in tele consultation services and distribution of medicines in the rural belt.

The pharmacy retail industry in India is operates majorly in the unorganized format and is currently having approximately 12 major players operating in organized format. However, most organized players are operative regionally and are far from having a pan India presence. A variety of value added services are being incorporated by the organized players to attract a larger market share and initiatives are being taken to engage customers in brand loyalty.

To sum up, the pharmacy retail is a stable market that has strong growth potential even in the future years.

READ MORE

Table Of Content

Scope

Slide 1: Executive Summary

Macroeconomic Indicators

Slide 2: Economic Indicators: GDP at cost factor cost: Quarterly (2009-10- 2012-13) & Inflation rate Monthly (Aug-Sep 2012-Dec-Jan 2013)

Slide 3: Gross fiscal deficit: Monthly (Sep-2011-Feb 2012) & Exchange Rate: Monthly (Sep 2012- Feb 2013)

Slide 4: Lending rate: Annual (2008-09-2011-12); Trade Balance: Annual (2009-10-2012-13) & FDI: Annual (2009-10-2012-13)

Introduction

Slide 5-7: Healthcare Industry Overview

Slide 8: Comparative study between Pharmacy Chain Retailing and Traditional Medical Retailing

Slide 9: Evolving role of Pharmacy Retail

Slide 10: Pharmacy Retail Store Formats

Market Overview

Slide 11: Pharmacy Retail: Market Size & Growth and Market Segmentation

Slide 12: Distribution Channel

Role of Government

Slide 13: Summary

Slide 14-15: Role of Government in Pharmacy Retail

Slide 16: Drugs & Cosmetics Act 1940

Drivers & Challenges

Slide 17: Summary

Slide 18-23: Key Drivers

Slide 24-27: Key Challenges

Industry Association

Slide 28: All India Organization of Chemists and Druggists (AIOCD)

Key Trends

Slide 29: Summary

Slide 30-35: Key Trends in Pharmacy Retail

Technology Adoption

Slide 36: Summary

Slide 37-38: Technology Adoption in Pharmacy Retail

Competitive Landscape

Slide 39: Market Competition- Porter's Five Forces Analysis

Slide 40-42: Competitive Benchmarking

Slide 43-55: Major Public Player- Corporate information, financial snapshot and summary key ratios, key business and geographic segments, business highlights and SWOT analysis

Slide 56: Major Private Companies-Summary

Slide 57-101: Major Private Players- Corporate information, ownership and shareholding structure of company, financial snapshot, key ratios, business highlights and SWOT analysis

Slide 102: Some other players in Indian market

Strategic Insights

Slide 103: Key Strategic Recommendations

Appendix

Slide 104: Appendix

Slide 105: Sources of Information


List Of Figure

Macroeconomic Indicators

1. GDP at cost factor cost: Quarterly (2009-10- 2012-13)

2. Inflation rate Monthly (Aug-Sep 2012-Dec 2012-Jan 2013)

3. Gross fiscal deficit: Monthly (Sep-2011-Feb 2012)

4. Exchange rate: Monthly (Sep 2012- Feb 2013)

5. Lending rate: Annual (2008-09-2011-12)

6. Trade balance: Annual (2009-10-2012-13)

7. FDI: Annual (2009-10-2012-13)

Introduction

8. Healthcare sector: Market size and growth (2012-16e)

9. Healthcare market segmentation: 2012

10. Healthcare expenditure of population by economic standard

Market Overview

11. Pharmacy Retail: Market Size & Growth (Value wise) (2012-2017e)

12. Market Segmentation: Organized and Unorganized (Percent wise) (2012-2017e)

Drivers & Challenges

13. Pharmaceutical Sector: Market Size and Growth (Value-wise) (2011 and 2016e)

14. Middle Class Population Growth Projection (2010-2025e)

15. Average Health Spending-(2011-12)

16. OOP Healthcare Expenditure (Select States of Country)

17. Prevalence of Chronic Lifestyle Diseases in India (2011 and 2016e)

18. OTC and Prescription Drugs Sales Segmentation-2012

19. Growth of OTC Market in India (2012 and 2017e)

20. Consumer Behavior to Minor Ailments

21. Trend of Counterfeit Drugs in India (2009-10-2011-12)

22. State-wise Sub Standard Drug Distribution

Technology Adoption

23. IT Adoption in Retail Pharmacy

Competitive Landscape

24. Competitive Benchmarking of Major 3 Private Companies-Operational Basis

25. Company Profiles (All Companies)

a. Financial Snapshot

(Except for The Himalaya Drug Company)

b. Share of Revenue from Respective Verticals: Apollo Pharmacy Ltd.

c. Ownership Structure (Private Companies)


List Of Table

Drivers & Challenges

1. Profit Margin earned by Pharmacy Retail

Key Trends

2. Loyalty Schemes introduced by Pharmacy Retail Players

3. Value Added Services by Pharmacy Retail Players

4. Tele Consultation Service Providers

5. Rural Expansion by Pharmacy Retail Players

Competitive Landscape

5. Company Profiles (All Companies)

a. Company Information

b. Products and Services

c. Key People

d. Key Financial Performance Indicators (for Public Company)

e. Shareholders of the Company (for Private Companies only)

f. Key Ratios

g. Business Highlights

h. Some other players in Indian market

Appendix

7. Appendix

8. Sources of Information

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Private Companies

1. Apollo Pharmacy Ltd.

2. Dialforhealth India Ltd.

3. VIVA - Your Family Chemist

4. Emami Frank Ross Ltd.

5. Guardian Lifecare Pvt. Ltd.

6. Medica Health Shoppe

7. MedPlus Health Services Pvt. Ltd.

8. Muthu Pharmacy Pvt.

9. 98.4

10. Religare Wellness Ltd.

11. The Himalaya Drug Company

12. Trust Chemists and Druggists Ltd.

Company Profile

Company Profile Title

The new report, "Pharmacy Retail Market in India", elaborates the changing role of pharmacy outlets and the gradual progression it is seeing towards building an organized format. The market is sustainable and is projected towards significant growth due to the already existing varied disease profile as well as the emerging new diseases and the growing population size being affected by such diseases.

The pharmacy sector forms the second largest share in the Indian healthcare sector. The sector sources its products through institutional and non institutional sales. The institutional sales is the sale of pharmaceuticals to hospitals, nursing homes and other such health institutions that purchase bulk drugs at discounted prices that results in partial decline in profit margin of manufacturers. Whereas, non institutional sales takes place through retail stores that happen to be the only form of sales channel that reaches directly to consumers and is a major source of revenue earning for the sector.

The pharmacy sector in India is highly regulated yet the sector suffers from circulation of sub standard and counterfeit drugs which hampers the retail segment of the business. Measures are being taken by the pharmacy regulatory bodies of the country to control the menace as it hampers the revenue earning drastically. The government is also taking major initiatives to provide medicines at subsidized rates as well as engage in tele consultation services and distribution of medicines in the rural belt.

The pharmacy retail industry in India is operates majorly in the unorganized format and is currently having approximately 12 major players operating in organized format. However, most organized players are operative regionally and are far from having a pan India presence. A variety of value added services are being incorporated by the organized players to attract a larger market share and initiatives are being taken to engage customers in brand loyalty.

To sum up, the pharmacy retail is a stable market that has strong growth potential even in the future years.

READ MORE

Scope

Slide 1: Executive Summary

Macroeconomic Indicators

Slide 2: Economic Indicators: GDP at cost factor cost: Quarterly (2009-10- 2012-13) & Inflation rate Monthly (Aug-Sep 2012-Dec-Jan 2013)

Slide 3: Gross fiscal deficit: Monthly (Sep-2011-Feb 2012) & Exchange Rate: Monthly (Sep 2012- Feb 2013)

Slide 4: Lending rate: Annual (2008-09-2011-12); Trade Balance: Annual (2009-10-2012-13) & FDI: Annual (2009-10-2012-13)

Introduction

Slide 5-7: Healthcare Industry Overview

Slide 8: Comparative study between Pharmacy Chain Retailing and Traditional Medical Retailing

Slide 9: Evolving role of Pharmacy Retail

Slide 10: Pharmacy Retail Store Formats

Market Overview

Slide 11: Pharmacy Retail: Market Size & Growth and Market Segmentation

Slide 12: Distribution Channel

Role of Government

Slide 13: Summary

Slide 14-15: Role of Government in Pharmacy Retail

Slide 16: Drugs & Cosmetics Act 1940

Drivers & Challenges

Slide 17: Summary

Slide 18-23: Key Drivers

Slide 24-27: Key Challenges

Industry Association

Slide 28: All India Organization of Chemists and Druggists (AIOCD)

Key Trends

Slide 29: Summary

Slide 30-35: Key Trends in Pharmacy Retail

Technology Adoption

Slide 36: Summary

Slide 37-38: Technology Adoption in Pharmacy Retail

Competitive Landscape

Slide 39: Market Competition- Porter's Five Forces Analysis

Slide 40-42: Competitive Benchmarking

Slide 43-55: Major Public Player- Corporate information, financial snapshot and summary key ratios, key business and geographic segments, business highlights and SWOT analysis

Slide 56: Major Private Companies-Summary

Slide 57-101: Major Private Players- Corporate information, ownership and shareholding structure of company, financial snapshot, key ratios, business highlights and SWOT analysis

Slide 102: Some other players in Indian market

Strategic Insights

Slide 103: Key Strategic Recommendations

Appendix

Slide 104: Appendix

Slide 105: Sources of Information


List Of Figure

Macroeconomic Indicators

1. GDP at cost factor cost: Quarterly (2009-10- 2012-13)

2. Inflation rate Monthly (Aug-Sep 2012-Dec 2012-Jan 2013)

3. Gross fiscal deficit: Monthly (Sep-2011-Feb 2012)

4. Exchange rate: Monthly (Sep 2012- Feb 2013)

5. Lending rate: Annual (2008-09-2011-12)

6. Trade balance: Annual (2009-10-2012-13)

7. FDI: Annual (2009-10-2012-13)

Introduction

8. Healthcare sector: Market size and growth (2012-16e)

9. Healthcare market segmentation: 2012

10. Healthcare expenditure of population by economic standard

Market Overview

11. Pharmacy Retail: Market Size & Growth (Value wise) (2012-2017e)

12. Market Segmentation: Organized and Unorganized (Percent wise) (2012-2017e)

Drivers & Challenges

13. Pharmaceutical Sector: Market Size and Growth (Value-wise) (2011 and 2016e)

14. Middle Class Population Growth Projection (2010-2025e)

15. Average Health Spending-(2011-12)

16. OOP Healthcare Expenditure (Select States of Country)

17. Prevalence of Chronic Lifestyle Diseases in India (2011 and 2016e)

18. OTC and Prescription Drugs Sales Segmentation-2012

19. Growth of OTC Market in India (2012 and 2017e)

20. Consumer Behavior to Minor Ailments

21. Trend of Counterfeit Drugs in India (2009-10-2011-12)

22. State-wise Sub Standard Drug Distribution

Technology Adoption

23. IT Adoption in Retail Pharmacy

Competitive Landscape

24. Competitive Benchmarking of Major 3 Private Companies-Operational Basis

25. Company Profiles (All Companies)

a. Financial Snapshot

(Except for The Himalaya Drug Company)

b. Share of Revenue from Respective Verticals: Apollo Pharmacy Ltd.

c. Ownership Structure (Private Companies)


List Of Table

Drivers & Challenges

1. Profit Margin earned by Pharmacy Retail

Key Trends

2. Loyalty Schemes introduced by Pharmacy Retail Players

3. Value Added Services by Pharmacy Retail Players

4. Tele Consultation Service Providers

5. Rural Expansion by Pharmacy Retail Players

Competitive Landscape

5. Company Profiles (All Companies)

a. Company Information

b. Products and Services

c. Key People

d. Key Financial Performance Indicators (for Public Company)

e. Shareholders of the Company (for Private Companies only)

f. Key Ratios

g. Business Highlights

h. Some other players in Indian market

Appendix

7. Appendix

8. Sources of Information

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Private Companies

1. Apollo Pharmacy Ltd.

2. Dialforhealth India Ltd.

3. VIVA - Your Family Chemist

4. Emami Frank Ross Ltd.

5. Guardian Lifecare Pvt. Ltd.

6. Medica Health Shoppe

7. MedPlus Health Services Pvt. Ltd.

8. Muthu Pharmacy Pvt.

9. 98.4

10. Religare Wellness Ltd.

11. The Himalaya Drug Company

12. Trust Chemists and Druggists Ltd.